Latest Tech News

Stay updated with the latest in technology, AI, cybersecurity, and more

Filtered by: rug Clear Filter

Police Puzzled by 180 Kilos of SpaceX-Branded Cocaine Found at Crash Site

A single-engine plane crashed landed in a field of sugar cane in Brazil over the weekend, according to local news media Alagoas 24 Horas, killing the pilot and leaving behind 180 kilograms — or almost 400 pounds — of cocaine. So far, it just sounds like a tale of drug smuggling gone awry. Except that the coke, stacked together in neat bricks and wrapped in plastic, as shown in a video from local police obtained by Alagoas, sported a distinctive label: the official SpaceX logo, in blue and white

Eli Lilly to Build $5 Billion Drug Manufacturing Plant in Virginia

Eli Lilly announced plans on Tuesday to build a $5 billion drug manufacturing facility in Virginia. The announcement comes amid pressure from President Donald Trump to bring more drug manufacturing to the U.S. and threats to slap heavy tariffs on pharmaceuticals coming from overseas. The new manufacturing plant will be built west of Richmond, Virginia, in Goochland County, according to a press release from the company. Eli Lilly says it expects the project to be completed in five years and clai

Harvard's new free AI tool could help treat Parkinson's, Alzheimer's, and even cancer

Nemes Laszlo/Science Photo Library/Getty Images Follow ZDNET: Add us as a preferred source on Google. ZDNET's key takeaways Harvard researchers designed a new AI model, PDGrapher. It can identify treatments to restore diseased cells to health. This could have larger impacts on drug discovery. While AI's most common use cases involve helping people with their everyday tasks, it can also go far beyond that, even helping make medical breakthroughs. Also: Can AI outdiagnose doctors? Microsoft

The SSD version of LaCie’s iconic Rugged drive gets a speed boost

is a senior reporter who’s been covering and reviewing the latest gadgets and tech since 2006, but has loved all things electronic since he was a kid. Posts from this author will be added to your daily email digest and your homepage feed. Neil Poulton succeeded in elevating the design of external drives two decades ago with the introduction of LaCie’s Rugged line, which features a bright orange bumper to protect data from drops. Today, Seagate announced an updated version of the LaCie Rugged M

Experimental Cream Could Make ‘Permanent’ Scars a Thing of the Past

Cool guys may have scars, but plenty of people would relish the opportunity to get rid of their own. In new research out this week, an experimental drug has shown promise at being able to clear up lingering scar tissue. Scientists in Australia conducted the study, a phase I trial of a tropical cream developed by the company Syntara. People applying the cream experienced no major side effects, they found, and the drug appeared to trigger changes in the skin within older, or mature, scars. Though

Topics: 6302 drug scars skin snt

Rug pulls, forks, and open-source feudalism

Rug pulls, forks, and open-source feudalism [LWN subscriber-only content] Welcome to LWN.net The following subscription-only content has been made available to you by an LWN subscriber. Thousands of subscribers depend on LWN for the best news from the Linux and free software communities. If you enjoy this article, please consider subscribing to LWN. Thank you for visiting LWN.net! Like almost all human endeavors, open-source software development involves a range of power dynamics. Companies, d

Ozempic Is an ‘Essential’ Drug, WHO Says as Agency Calls for Cheaper Generics

One of the world’s most sought-after drugs has officially become a vital medication. The World Health Organization has just added semaglutide—the active ingredient in Ozempic and Wegovy—to its list of essential medicines. The WHO’s Model Lists of Essential Medicines is designed to improve affordability and access for the world’s most impactful drugs. Semaglutide and other GLP-1 drugs are among 20 new additions to the list, and it’s clear why. GLP-1s have completely reshaped how clinicians treat

The Government Is Preparing to Take Away Your SSRIs

Image by Chip Somodevilla / Getty / Futurism Mental Health Robert F. Kennedy, Jr., the well-heeled crackpot helming our nation's healthcare system, holds all kinds of screwball beliefs about pharmaceuticals — but his bizarre and incoherent opposition to depression-treating selective serotonin reuptake inhibitors (SSRIs) is perhaps the most indefensible. Since at least 2023, when Kennedy first launched his long-shot presidential campaign, the conspiracy theorist has insisted there is some sort

Could a tablet survive a real hike? This Samsung Galaxy model did - and I'd bring it again

Samsung Galaxy Tab Active5 Pro ZDNET's key takeaways The Samsung Galaxy Tab Active5 Pro is available starting at $659 for the 128GB version, with 5G models starting at $769. It's an exceptionally rugged tablet with removable dual batteries and software updates for eight years. RAM is a bit limited at 6GB, and the included S Pen doesn't support wireless Bluetooth functions. View now at Samsung Follow ZDNET: Add us as a preferred source on Google. A couple of months ago I popped the SIM out of

What Tech Jobs Don’t Drug Test? That Might Depend

Workers who live in states where cannabis is legal often face a conundrum. Can they continue using a substance deemed by lawmakers to be fit for public consumption, even if they may have an employer who might drug test? Or do they avoid it all together, because they don’t know what their employer’s drug policy is? And does that policy include only “hard” drugs like cocaine, opioids or methamphetamines, or does it test for cannabis too? These days, the answer is a lot more flexible than it was

Mark Cuban’s war on America’s $5 trillion healthcare machine: ‘They can’t react as quickly’

Billionaire entrepreneur and investor Mark Cuban thinks America’s healthcare industry is broken, and he’s not mincing words about it. “No one looks at the financial side of healthcare and says, ‘This is the way it should work,’” Cuban said on this week’s episode of the Equity podcast. “When you go to the doctor and you get a prescription . . . you have no idea what the cost to you is going to be. You don’t know if you can afford it or not.” The former “Shark Tank” host and minority owner of th

A Pill to Fight Obesity Is on the Verge of Approval

The next big obesity medication coming down the pipeline will likely come in pill form. Eli Lilly has just released the latest positive Phase III trial results of its experimental oral GLP-1 drug, orforglipron. On Tuesday morning, Eli Lilly reported that orforglipron met the benchmarks of the company’s Phase III ATTAIN-2 study. People taking orforglipron experienced substantial improvements in weight loss and blood sugar control compared to those taking a placebo, the study showed. Armed with d

Grug Design

🗿 note: grug brained developer help many dev. now grug designer start same long walk. original grug show way for code. this grug follow path for design. grug make design. grug not know much. but grug know pain. grug try to avoid pain. grug learn over many fire-cycles. complexity bad design tool have many button. design system have many rule. too many rule = grug scream. grug say: "if design need manual, design too complex." grug want small number of shapes, big number of meaning. grug make

Topics: design grug like say user

America’s fragile drug supply chain is extremely vulnerable to climate change

When Hurricane Helene ravaged western North Carolina in September 2024, one of its many victims was a manufacturing plant that made intravenous fluids. The sterile IV solutions produced in the plant are essential supplies for hospitals and other medical facilities, which use them in various treatments, from rehydration to drug delivery and kidney dialysis. And the plant damaged by Helene—Baxter International's North Cove manufacturing facility in Marion—didn't just make some of the US supply; it

Why my new favorite Samsung tablet model isn't the FE or Ultra (and it's full of surprises)

Samsung Galaxy Tab Active5 Pro ZDNET's key takeaways The Samsung Galaxy Tab Active5 Pro is available starting at $659 for the 128GB version, with 5G models starting at $769. It's an exceptionally rugged tablet with removable dual batteries and software updates for eight years. RAM is a bit limited at 6GB, and the included S Pen doesn't support wireless Bluetooth functions. View now at Samsung Get more in-depth ZDNET tech coverage: Add us as a preferred Google source on Chrome and Chromium bro

Generative AI Gave MIT Scientists a New Tool to Fight Antibiotic-Resistant Bacteria

Antibiotic-resistant bacteria are dangerous because they already "know" what most antibiotics look like. Scientists at MIT have found a way to create something new: using generative AI to design two antibiotic compounds from scratch that can kill drug-resistant gonorrhea and MRSA in lab dishes and mice. Antibiotic resistance is one of the world's biggest public health threats yet new antibiotics have been scarce for decades. Traditional drug discovery methods rely on screening known chemical li

I brought Samsung's rugged Galaxy tablet on a hiking trip, and it weathered everything

Samsung Galaxy Tab Active5 Pro ZDNET's key takeaways The Samsung Galaxy Tab Active5 Pro is available starting at $659 for the 128GB version, with 5G models starting at $769. It's an exceptionally rugged tablet with removable dual batteries and software updates for eight years. RAM is a bit limited at 6GB, and the included S Pen doesn't support wireless Bluetooth functions. View now at Samsung Get more in-depth ZDNET tech coverage: Add us as a preferred Google source on Chrome and Chromium bro

ADHD drug treatment and risk of negative events and outcomes

Conclusions Drug treatment for ADHD was associated with beneficial effects in reducing the risks of suicidal behaviours, substance misuse, transport accidents, and criminality but not accidental injuries when considering first event rate. The risk reductions were more pronounced for recurrent events, with reduced rates for all five outcomes. This target trial emulation study using national register data provides evidence that is representative of patients in routine clinical settings. Results O

I tested this fully-equipped Samsung tablet that makes the Ultra model look bad

Samsung Galaxy Tab Active5 Pro ZDNET's key takeaways The Samsung Galaxy Tab Active5 Pro is available starting at $659 for the 128GB version, with 5G models starting at $769. It's an exceptionally rugged tablet with removable dual batteries and software updates for eight years. RAM is a bit limited at 6GB, and the included S Pen doesn't support wireless Bluetooth functions. View now at Samsung Get more in-depth ZDNET tech coverage: Add us as a preferred Google source on Chrome and Chromium bro

I've tested several Android tablets for work travel - why I recommend this Samsung the most

Samsung Galaxy Tab Active5 Pro ZDNET's key takeaways The Samsung Galaxy Tab Active5 Pro is available starting at $659 for the 128GB version, with 5G models starting at $769. It's an exceptionally rugged tablet with removable dual batteries and software updates for eight years. RAM is a bit limited at 6GB, and the included S Pen doesn't support wireless Bluetooth functions. View now at Samsung Get more in-depth ZDNET tech coverage: Add us as a preferred Google source on Chrome and Chromium bro

I brought Samsung's new rugged tablet on a mountain lake trek - here's how it fared

Samsung Galaxy Tab Active5 Pro ZDNET's key takeaways The Samsung Galaxy Tab Active5 Pro is available starting at $659 for the 128GB version, with 5G models starting at $769. It's an exceptionally rugged tablet with removable dual batteries and software updates for eight years. RAM is a bit limited at 6GB, and the included S Pen doesn't support wireless Bluetooth functions. View now at Samsung Get more in-depth ZDNET tech coverage: Add us as a preferred Google source on Chrome and Chromium bro

New treatment eliminates bladder cancer in 82% of patients

TAR-200 is a miniature, pretzel-shaped drug-device duo containing a chemotherapy drug, gemcitabine, which is inserted into the bladder through a catheter and releases the drug for three weeks per treatment cycle. How the drug delivery system works TAR-200 is a miniature, pretzel-shaped drug-device duo containing a chemotherapy drug, gemcitabine, which is inserted into the bladder through a catheter. Once inside the bladder, the TAR-200 slowly and consistently releases the gemcitabine into the

The Creator of Ozempic Is in Terrible Trouble

Image by Mads Claus Rasmussen / Ritzau Scanpix / AFP via Getty / Futurism Developments While its customer are shedding pounds, Novo Nordisk, creator of the mega-hit drug Ozempic, is shedding loads of market value amid collapsing sales. One year ago, the Danish pharmaceutical giant's market cap exceeded the size of its entire home country's economy. But this week, it's continued its steady but drastic decline — which saw its CEO get the axe — by losing nearly $100 billion in value after slashin

Kyoto University team develops pain reliever comparable to morphine

A Kyoto University research team has developed a pain-reliever that is comparable to morphine but does not have serious side effects. Morphine, often administered to cancer patients, has serious adverse effects such as breathing issues and addiction. According to the team, the newly developed drug, Adriana, is a groundbreaking painkiller, which works on a completely different mechanism to morphine and other existing synthetic opioids. The drug has the potential to revolutionize pain control in

Feds Launch Experiment to Have Medicare Cover GLP-1 Weight Loss Drugs

The federal government may not have closed the window on paying for GLP-1 weight loss drugs like Ozempic and Zepbound after all. The Trump administration is reportedly planning to conduct an experiment that will allow some people to have obesity drugs covered by their Medicaid and Medicare plans. The Washington Post first broke the news Friday morning, having reportedly obtained documents from the Centers for Medicare and Medicaid Services outlining the plan. It would enable state Medicaid prog

Non-Hormonal Male Birth Control Pill Passes Key Test

For many couples, the numerous options for birth control still come with plenty of hassles. But scientists are working on an alternative approach that might be more appealing for some: a non-hormonal male birth control pill with possibly very few side effects. The drug is codenamed YCT-529, and it’s being developed by the company YourChoice Therapeutics, in conjunction with researchers from the University of Minnesota and others. In early human trial results published this week, YCT-529 appeare

The FDA Is Using an AI to "Speed Up" Drug Approvals and Insiders Say It's Making Horrible Mistakes

Image by Getty / Futurism Developments Insiders at the Food and Drug Administration are ringing alarm bells over the agency's use of an AI to fast-track drug approvals. As CNN reports, six current and former FDA officials are warning that the AI, dubbed Elsa, which was unveiled weeks earlier, is "hallucinating" completely made-up studies. It's a terrifying reality that could, in a worst-case scenario, lead to potentially dangerous drugs mistakenly getting the stamp of approval from the FDA.

Topics: ai drug elsa fda time

This industrial AI startup is winning over customers by saying it won’t get acquired

When industrial AI startup CVector meets with manufacturers, utility providers, and other prospective customers, the founders are often asked the same question: will you still be here in six months? A year? It’s a fair concern in an environment where the biggest, richest tech companies are luring top talent with eye-watering salaries and increasingly targeting rising AI startups with elaborate acquihire deals. The answer that CVector founders Richard Zhang and Tyler Ruggles give every time is

This Experimental Weight Loss Drug Works Without the Nausea or Vomiting

What if you could lose weight with a drug that won’t make you lose your lunch at the same time? New research shows it might be possible. Scientists at the University of Pennsylvania, the University of Kentucky, and other institutions say they’ve found a potentially novel way to suppress people’s appetite and treat obesity—without causing the nausea or vomiting commonly experienced with semaglutide (the active ingredient in Ozempic and Wegovy). In early animal experiments, the team’s experimenta

Doctors Say Ozempic Is Wildly Effective at Helping Addicts Beat Cravings

Image by Getty / Futurism Rx/Medicines Drugs like Ozempic and Wegovy already had a lengthening laundry list of physical health benefits, but now they're increasingly showing promise as treatments for neuropsychological conditions as well. Specifically, one of the most intriguing potential uses for these GLP-1 drugs is in addiction treatment, for vices ranging from alcohol to opioids to stimulants to gambling. And it's gaining momentum: as STAT News reports, one posh Pennsylvania rehabilitation